Moneycontrol PRO
ipca laboratories
Jump to
391 Results Found
  • Cipla may test Rs 491, IPCA Labs Rs 477: Rajat Bose Jun 10, 2016 11:03 AM IST

    Cipla may test Rs 491, IPCA Labs Rs 477: Rajat Bose

    Rajat Bose of rajatkbose.com is of the view that Cipla may test Rs 491 while IPCA Labs may hit Rs 477.

  • CLSA upgrades IPCA Labs but cuts EPS on flat sales guidance Jun 08, 2016 12:58 PM IST

    CLSA upgrades IPCA Labs but cuts EPS on flat sales guidance

    IPCA has lost 50 percent of its market cap in the past year due to the US FDA issues at three facilities and its impact on other businesses. According to the brokerage firm, India business growth has remained resilient in the turmoil.

  • Buy State Bank of India, ICICI Bank, IPCA Labs: Rajat Bose Jun 08, 2016 09:39 AM IST

    Buy State Bank of India, ICICI Bank, IPCA Labs: Rajat Bose

    Rajat Bose of rajatkbose.com recommends buying ICICI Bank, State Bank of India and IPCA Laboratories.

  • Ipca Labs Q4 profit doubles to Rs 38 cr, EBITDA jumps 72% May 30, 2016 01:30 PM IST

    Ipca Labs Q4 profit doubles to Rs 38 cr, EBITDA jumps 72%

    Operating profit (EBITDA - earnings before interest, tax, depreciation and amortisation) shot up 72.2 percent to Rs 63.5 crore and margin expanded by 440 basis points to 10.2 percent in Q4.

  • Here are top 10 stocks to focus on April 26 Apr 26, 2016 08:27 AM IST

    Here are top 10 stocks to focus on April 26

    CNBC-TV18's analysts gives stocks to keep on your radar for trade today - stocks expected to be under pressure today are ABB India, IPCA Labs, State Bank of Travancore, Sun Pharma, ITC, Godfrey Phillips and VST Industries while the stocks expected to gain are Indiabulls Housing, Bharti Airtel, Shilcar Tech, Novartis India and Excel Crop Care.

  • Sell Ipca Labs; target of Rs 440: Edelweiss Apr 12, 2016 04:58 PM IST

    Sell Ipca Labs; target of Rs 440: Edelweiss

    Edelweiss is bearish on Ipca Labs has recommended reduce rating on the stock with a target price of Rs 440 in its research report dated April 7, 2016.

  • Top buzzing midcap stocks to trade on April 8 Apr 08, 2016 01:55 PM IST

    Top buzzing midcap stocks to trade on April 8

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Tata Power, Ipca Labarotories, Reliance Infrastructure, BHEL, JSPL, Sagar Cement, Rajshree Sugar and Ricoh India.

  • Buy India Cements, Havells India: Ashwani Gujral Apr 08, 2016 11:45 AM IST

    Buy India Cements, Havells India: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy India Cements and Havells India.

  • Geneva-based fund not to order drug from Ipca, stock cracks 14% Apr 08, 2016 09:53 AM IST

    Geneva-based fund not to order drug from Ipca, stock cracks 14%

    Ipca received warning letter from USFDA for its Ratlam (Madhya Pradesh), SEZ Indore (Pithampur) and Piparia (Silvassa) manufacturing units.

  • Positive on IPCA, but see 4% impact on earnings: Phillip Capital Apr 08, 2016 09:13 AM IST

    Positive on IPCA, but see 4% impact on earnings: Phillip Capital

    Surya Patra, pharma analyst at Phillip Capital now estimates IPCA's institutional revenues to fall to around Rs 200 crore, from its earlier estimate of around Rs 260 crore

  • Geneva-based fund not to source malaria drug from Ipca Labs Apr 08, 2016 08:52 AM IST

    Geneva-based fund not to source malaria drug from Ipca Labs

    In a regulatory filing, Ipca Laboratories said the Geneva-based organisation that provides financial aid against AIDS, tuberculosis and malaria, has informed the company about its decision on Wednesday via a letter.

  • BHEL, Cairn India, NMDC among stocks in focus on D-Street Apr 08, 2016 08:44 AM IST

    BHEL, Cairn India, NMDC among stocks in focus on D-Street

    Here are stocks likely to be in the limelight in today's trade

  • Stocks in news: Cairn, NMDC, Ipca Lab, Sagar Cement, RComm, NBCC Apr 08, 2016 08:17 AM IST

    Stocks in news: Cairn, NMDC, Ipca Lab, Sagar Cement, RComm, NBCC

    Cairn India | NMDC | Ipca Labs | Adani Enterprises | Sagar Cement | NBCC | IVRCL | PNC Infratech | Jyoti Structures | Simplex Projects and Reliance Communications are stocks, which are in the news today.

  • Christiani & Nielsen looks to buy majority stake in Gammon arm Mar 23, 2016 02:44 PM IST

    Christiani & Nielsen looks to buy majority stake in Gammon arm

    The valuation of the deal would be around Rs 250-300 crore, say sources, adding IPCA Labs had already invested in Gammon's transmission and distribution business.

  • Aim is to prevent rampant use of antibiotics: P Lilladher Mar 14, 2016 09:18 AM IST

    Aim is to prevent rampant use of antibiotics: P Lilladher

    Hailing the government's move, Surajit Pal, pharma analyst at Prabhudas Lilladher, says the aim of regulation is to prevent rampant use of antibiotics. He says Abbott is likely to be severely impacted by the move as it has around 15.4 percent exposure to fixed-dosed combinations.

  • Lower malaria opportunity in Africa, pricing policy may hit IPCA Mar 09, 2016 12:32 PM IST

    Lower malaria opportunity in Africa, pricing policy may hit IPCA

    According to Credit Suisse, slower ramp-up in malaria tender business in Africa, pricing policy hit in India portfolio starting April 2016 and potential nine-month delay in resolution in the US post the warning letter may have combined impact of 17 percent to FY17 earnings per share (EPS) and 11 percent to FY18 EPS.

  • FDA finds data manipulation, norm violations at 3 Ipca plants Feb 16, 2016 08:02 AM IST

    FDA finds data manipulation, norm violations at 3 Ipca plants

    According to the warning letter sent by the USFDA over the three plants, its inspectors observed systemic data manipulation and other current good manufacturing practices (CGMP) violations and deviations at the company's three facilities.

  • Motilal Oswal: neutral on Ipca Labs; target of Rs 680 Feb 10, 2016 02:08 PM IST

    Motilal Oswal: neutral on Ipca Labs; target of Rs 680

    Motilal Oswal has recommended neutral rating on Ipca Labs with a target price of Rs 680 in its research report dated February 8, 2016.

  • Ipca Labs Q3 profit falls 44%, revenue down 8% on lower exports Feb 08, 2016 01:07 PM IST

    Ipca Labs Q3 profit falls 44%, revenue down 8% on lower exports

    Operating profit (earnings before interest, tax, depreciation and amortisation) in October-December period dropped 26 percent to Rs 89.25 crore and margin contracted by 331 basis points to 13.05 percent compared to corresponding quarter of last fiscal.

  • Ipca Labs gets USFDA warning letter for 3 units, stock crashes Feb 01, 2016 12:35 PM IST

    Ipca Labs gets USFDA warning letter for 3 units, stock crashes

    Ipca Labs already voluntarily suspended shipments of its APIs and formulations for the US market till USFDA inspection observations are resolved.

  • Prefer Ipca Laboratories, says Mayuresh Joshi Jan 05, 2016 03:33 PM IST

    Prefer Ipca Laboratories, says Mayuresh Joshi

    Mayuresh Joshi of Angel Broking is of the view that one may prefer Ipca Laboratories.

  • Pick Ipca Lab, Siemens: Amit Harchekar Jan 01, 2016 03:05 PM IST

    Pick Ipca Lab, Siemens: Amit Harchekar

    Amit Harchekar of A-Plus Analytics is of the view that one may pick Ipca Laboratories and Siemens.

  • Ipca Laboratories may test Rs 900, says Mayuresh Joshi Dec 14, 2015 05:01 PM IST

    Ipca Laboratories may test Rs 900, says Mayuresh Joshi

    Mayuresh Joshi of Angel Broking feels that Ipca Laboratories may test Rs 900.

  • Buy Hindalco Industries, Marico, Ipca Labs: Rahul Mohindar Dec 01, 2015 02:37 PM IST

    Buy Hindalco Industries, Marico, Ipca Labs: Rahul Mohindar

    Rahul Mohindar of viratechindia.com recommends buying Hindalco Industries, Marico and Ipca Labs.

  • There is scope for further US FDA action: JM Financial Nov 16, 2015 04:00 PM IST

    There is scope for further US FDA action: JM Financial

    Sun Pharma and Dr Reddy‘s are long-term winners, Anmol Ganjoo, Pharma analyst at JM Financial said adding that there is still scopr for further US FDA actions.

Sections
ISO 27001 - BSI Assurance Mark